A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MGIT / Mycobacteria Growth Indicator Tube

[Related PubMed/MEDLINE]
Total Number of Papers: 330
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MGIT  (>> Co-occurring Abbreviation)
Long Form:   Mycobacteria Growth Indicator Tube
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 A Rare Case of Multidrug-Resistant Lupus Vulgaris with a Mixed Pattern of Resistance - A Long Journey to Diagnosis and Treatment. ATT, CBNAAT, MDR, TB, XDR
2022 Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid. AST, MTBC, Pa
2022 Comparative diagnostic utility of metagenomic next-generation sequencing, GeneXpert, modified Ziehl-Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A multi-center, retrospective study in China. CSF, mNGS, NPVs, TBM, ZN
2022 Detecting rifampin and isoniazid resistance in Mycobacterium tuberculosis direct from patient sputum using an automated integrated system. LFA
2022 Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations. MDR-TB, MIC, PAS
2022 Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice. AUCs, BALF, mNGS, NTM-PD, ROC
2022 Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis. MICs, MODS
2022 Evaluation of GeneXpert and liquid culture for detection of Mycobacterium tuberculosis in pediatric patients. AFB, Mtb
10  2022 High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis. CI, eCFU, LJ, TB-MBLA, Xpert ultra
11  2022 Pulmonary non-tuberculous mycobacteria in colonisation and disease in The Gambia. AFB, ATS/IDSA, NTM, PNTM, PNTM, TB
12  2022 Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia. AFB, EQA, IQC, PT
13  2022 Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy. CRP, IQR, TB, TB-MBLA, TTP
14  2022 Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed rpoB Mutations and Discordant Susceptibility Phenotypes. CC, ECOFF, MABA, Mtb, pDST, TB, TTP
15  2022 Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts. CFU, LAM, Mtb, TB
16  2022 Susceptibility pattern of Mycobacterium tuberculosis over a period of five years at Indus Hospital and Health Network, Karachi, Pakistan. DR
17  2022 Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures. AST, MTBC, SPH, WGS
18  2022 Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory. MALDI-TOF MS, NTM, RGM, SGM
19  2022 Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai. CBNAAT, DRT, DST, Mtb, NGS, PMDT, TB, WGS, WHO
20  2021 A Case of Colonic Tuberculosis Revealed by Polymerase Chain Reaction. LJ
21  2021 Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study. Ct, GEE, LJ, PLHIV, TTP
22  2021 Comparison of different diagnostic modalities for isolation of Mycobacterium Tuberculosis among suspected tuberculous lymphadenitis patients. AFB, DST, LJ, MDR, Mtb, RIF
23  2021 Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing. DST, MICs, NGS
24  2021 Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India. DR-TB, DST, FQs, MTBC, SLIDs, WHO
25  2021 Estimating TB diagnostic costs incurred under the National Tuberculosis Elimination Programme: a costing study from Tamil Nadu, South India. FM, LJ, LPA, MTB/RIF, NAAT, NTEP, ZN
26  2021 Evaluation of the performance of a novel sputum processing ReaSLR methodology for culture of sputum samples in solid and liquid media in comparison with modified Petroff's method. CDC, LJ, Mtb, NALC
27  2021 Improved detection of Mycobacterium tuberculosis and M. bovis in African wildlife samples using cationic peptide decontamination and mycobacterial culture supplementation. CFU, MTBC
28  2021 On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex. AST, CCs, FDA, RIF, WHO
29  2021 Pattern of Drug Resistance in Primary Spinal Tuberculosis: A Single-Center Study From India. MDR, pre-XDR, XDR
30  2021 Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South Africa. CI, HHCs, TB
31  2021 Performance of QuantaMatrix Microfluidic Agarose Channel system integrated with mycobacteria growth indicator tube liquid culture. DST, LJ, QMAC
32  2021 Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India. AP, EPTB, ICT, IRL, LJ, LPA, MTBC, NTM, PTB, TB, ZN
33  2021 Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013. aPR, CI, MDR-TB, MIC
34  2021 Supplementation of sputum cultures with culture filtrate to detect tuberculosis in a cross-sectional study of HIV-infected individuals. CF, TTP
35  2021 Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis. ANOVA, LPG, Mtb, NRP, SRB, TB
36  2021 The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures. TB
37  2020 Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial. CI, IQR, LJ, TB
38  2020 Combination of Xpert MTB/RIF and MTBDRplus for Diagnosing Tuberculosis in a Chinese District. MDR-TB, RIF, TB
39  2020 Comparison of diagnostic accuracy of the GeneXpert Ultra and cell-free nucleic acid assay for tuberculous meningitis: A multicentre prospective study. cfDNA, TBM
40  2020 Comparison of Diagnostic Yield of Tuberculosis Loop-Mediated Isothermal Amplification Assay With Cartridge-Based Nucleic Acid Amplification Test, Acid-Fast Bacilli Microscopy, and Mycobacteria Growth Indicator Tube Culture in Children With Pulmonary Tuberculosis. AFB, CBNAAT, CI, Mtb, TB
41  2020 Diagnostic performance of real time PCR and MALDI-TOF in the detection of nontuberculous mycobacteria from clinical isolates. AS, CM, LPA, MTBC, NTM
42  2020 Effect of specimen processing, growth supplement, and different metabolic population on Mycobacterium tuberculosis laboratory diagnosis. TTP
43  2020 Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens. RIF
44  2020 Evaluation of Various Diagnostic Techniques for the Diagnosis of Pulmonary and Extra Pulmonary Tuberculosis at a Tertiary Care Center in North India. TB
45  2020 Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India. MDR-TB, NRA, OFX, PCR
46  2020 High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda. PZA
47  2020 Low-Level Rifampin Resistance and rpoB Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York. MDR, RIF, WGS
48  2020 Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria. AFB, LJ, MDR-TB, TB
49  2020 Profile of Nontuberculous Mycobacteria in Patients Suspected of Tuberculosis and Drug-Resistant Tuberculosis. DR-TB, Mtb, NTM, PSC
50  2020 Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance study. MTBC, WGS
51  2020 The MPB64 immunochromatography assay: an analysis of doubtful results. MTBC, TB, TBcId, WHO
52  2020 The yield of Auramine O staining using led microscopy with bleach treated sputum samples for detection of pulmonary tuberculosis at St. Peter tuberculosis specialized hospital, Addis Ababa, Ethiopia. AFB, AO, LED, NPV, PPV, TB, WHO, ZN
53  2020 Utility of smear microscopy and GeneXpert for the detection of Mycobacterium tuberculosis in clinical samples. AFB, AO, Mtb, NPV, NTM, PPV, RIF, ZN
54  2020 Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study. AP, BMD, CCs, DST, EQA
55  2020 Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. CSF, Xpert Ultra
56  2019 Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones. FQ, LFX, TB
57  2019 Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting. AC, DST, Mtb, TATs
58  2019 An automated smear microscopy system to diagnose tuberculosis in a high-burden setting. MS, TB
59  2019 Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis. BMI, RePORT, TB, TTP
60  2019 Evaluation of a membrane hybridization array for detection of Mycobacterium tuberculosis complex and resistance to isoniazid and rifampin in sputum specimens, mycobacterial liquid cultures, and clinical isolates. MTBC, RIF
61  2019 Evaluation of Microscopic observation drug susceptibility (MODS) assay as a rapid, sensitive and inexpensive test for detection of tuberculosis and multidrug resistant tuberculosis. DST, LJ, MDR-TB, MODS, TB
62  2019 Evaluation of OMNIgene Sputum and Ethanol Reagent for Preservation of Sputum Prior to Xpert and Culture Testing in Uganda. OM-S
63  2019 Isolation and analysis of the molecular epidemiology and zoonotic significance of Mycobacterium tuberculosis in domestic and wildlife ruminants from three states in India. CAS, EAI, LJ, MB, MT, MTC, OADC, PCR
64  2019 Making a Positive Diagnosis of Intestinal Tuberculosis with the Aid of New Biologic and Histologic Features: How Far Have We Reached? CD, TB
65  2019 MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patients. PTB, TB
66  2019 MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia. DST
67  2019 Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture. MBL, TTP
68  2019 Molecular Bacterial Load Assay Concurs with Culture on NaOH-Induced Loss of Mycobacterium tuberculosis Viability. eCFU, MBLA, TB
69  2019 Multiplex Polymerase Chain Reaction for diagnosis of gastrointestinal tuberculosis. BACTEC, GITB, NPV, PCR, PPV
70  2019 Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. DST, HSR-rpoB, MAS, MDR-TB
71  2019 Performance of bioMerieux Lowenstein-Jensen slopes in plastic tube packaging, compared to existing phenotypic methods, for efficient recovery of the Mycobacterium tuberculosis complex. bMx, LJ, Mtb
72  2019 Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naive patients in Nairobi, Kenya. AG/CP, FQ, KAN, KEMRI, MDR-TB, NALC, RIF, TB, ZN
73  2019 Spoligotyping with pncA sequencing strategy conferring the transmission of multidrug-resistant tuberculosis in Egypt. DST, MDR, RIF
74  2019 Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania. HRM, KCRI, LJ, MDR, TB
75  2019 Validation of the GenoType® MTBDRplus Ver 2.0 assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates at UZCHS-CTRC TB research laboratory. AST, MDR-TB, RIF
76  2019 Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. DSTs, MODS, NRA, REMA, RR
77  2019 WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. DST, MTBC
78  2019 Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture. ---
79  2019 [Evaluation of Anyplex MTB/NTM Test for The Detection of Mycobacterium tuberculosis in Clinical Specimens]. PCR, RT-PCR
80  2018 Automated broth-based systems versus the MYCOTB plate for antimicrobial susceptibility testing of the Mycobacterium tuberculosis complex: challenges in interpretation. CC, EMB, MYCOTB, RIF
81  2018 Badgers as a potential source of bovine tuberculosis - first studies in Poland. bTB
82  2018 Cervical tuberculous lymphadenitis: Clinical profile and diagnostic modalities. EPTB, MTBC, PCR
83  2018 Comparison of Lowenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV. CI, HR, LJ, OR, TB
84  2018 Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing. WGS
85  2018 Do additional colonoscopic biopsies increase the yield of Mycobacterium tuberculosis culture in suspected ileo-colonic tuberculosis? CI, ITB
86  2018 Efficacy and role of Xpert® Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis. AFB, MTB/RIF
87  2018 Evaluation of manual Mycobacterium growth indicator tube for isolation and susceptibility testing of Mycobacterium tuberculosis for implementation in low and medium volume laboratories. DST, LJ, Mtb
88  2018 Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis. WGS
89  2018 Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study. ---
90  2018 Growth characteristics of liquid cultures increase the reliability of presumptive identification of Mycobacterium tuberculosis complex. DST, MTBC
91  2018 Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania. MIC
92  2018 Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol. DST, EMB, MDR-TB, PCR, SM
93  2018 OMNIgene.SPUTUM suppresses contaminants while maintaining Mycobacterium tuberculosis viability and obviates cold-chain transport. LJ, OM-S, SDP, TB
94  2018 Performance of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Specimens from Non-Cystic Fibrosis Patients. AFC, MALDI-TOF MS, NTM, RGM30
95  2018 rpoB Targeted Loop-Mediated Isothermal Amplification (LAMP) Assay for Consensus Detection of Mycobacteria Associated With Pulmonary Infections. LAMP
96  2018 The Role of MGIT 960 Culture Medium in Resolving the Diagnostic Dilemma for Genital Tuberculosis Patients Presenting with Infertility. GTB
97  2018 Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting. TB
98  2017 A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens. LJ
99  2017 A suggested algorithm for detection of multi drug-resistant tuberculosis in Zimbabwe. DST, LJ, MDR-TB, MODS, TAT
100  2017 Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India. DST, FQ, LVX, MDR-TB, MIC, MXF, OFX, RIF